About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Schizophrenia Study In Adults | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00049946

Schizophrenia Study In Adults

A Placebo Controlled Study For Patients With Schizophrenia

Lead sponsor: GlaxoSmithKline•31 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

GlaxoSmithKline

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patient must meet diagnostic criteria for schizophrenia.

Exclusion Criteria

•Patients with other psychotic disorders.
•Patients whose condition is due to the direct physiological effects of a substances (e.g., drug abuse) or a general medical condition.
•Patients with a history of autistic disorder or another pervasive developmental disorder.
•Patients with epilepsy or a history of seizures requiring treatment.
•Patients who are excluded from taking the drug risperidone.
•Patients who pose a current serious suicidal or homicidal risk.
•Patients who are adequately stabilized on their treatment.

Related studies

RECRUITINGPhase 3

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

NCT07565428 · Negative Symptoms of Schizophrenia

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more

Deep Brain Stimulation for Psychosis

NCT06257056 · Treatment-Refractory Schizophrenia

RECRUITINGPhase 2

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

NCT07288333 · Schizophrenia

RECRUITINGPhase 3

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

NCT07105098 · Schizophrenia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 16, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment231

Start dateOct 2002

Last updatedAug 16, 2017

Condition

Locations shown

GSK Clinical Trial Call Center

Scottsdale, Arizona

GSK Clinical Trial Call Center

Cerritos, California

GSK Clinical Trial Call Center

Chula Vista, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions